✦ LIBER ✦

CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel

✍ Scribed by Daniel L. Hertz, Alison A. Motsinger-Reif, Amy Drobish, Stacey J. Winham, Howard L. McLeod, Lisa A. Carey, E. Claire Dees

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1405 POSTER DISCUSSION Cyp2C19*2 Polymor

✍ K. Beelen; R. Koornstra; M. Opdam; T. Severson; A. Vincent; R.J. van Diest; S. L 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

CYP2C19*2predicts substantial tamoxifen

✍ K. Beelen, M. Opdam, T. M. Severson, R. H. T. Koornstra, A. D. Vincent, M. Haupt 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 263 KB

Impact of CYP3A5*3 and CYP2C8-HapC on pa

✍ Gréen, Henrik (author);Khan, Muhammad Suleman (author);Jakobsen-Falk, Ingrid (au 📂 Article 📅 2011 🏛 John Wiley and Sons Inc. 🌐 English ⚖ 133 KB

Impact of CYP3A5*3 and CYP2C8-HapC on pa

✍ Gréen, Henrik (author);Khan, Muhammad Suleman (author);Jakobsen-Falk, Ingrid (au 📂 Article 📅 2011 🏛 John Wiley and Sons Inc. 🌐 English ⚖ 133 KB

Pharmacokinetics of Paclitaxel in Ovaria

✍ Nakajima, Miki; Fujiki, Yuto; Kyo, Satoru; Kanaya, Taro; Nakamura, Mitsuhiro; Ma 📂 Article 📅 2005 🏛 Sage Publications 🌐 English ⚖ 223 KB

Plasma and Tissue Pharmacokinetics of Ep

✍ Hunz, M; Jetter, A; Warm, M; Pantke, E; Tuscher, M; Hempel, G; Jaehde, U; Untch, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 229 KB